Hesperos

Hesperos Inc. With over 20 years of expertise from founders Drs. Shuler and Hickman, Hesperos has established itself as the Original Human-on-a-Chip Company, providing patented systems for advanced drug testing and disease modeling. The company's cutting-edge technology offers a physiological model that reproduces various human diseases, enabling researchers to gain crucial insights into disease states and therapeutic responses.

Hesperos specializes in developing custom organ models, including the heart, liver, neurons, and kidney, to evaluate drug safety, efficacy, and interactions. Their systems facilitate a holistic view of organ functions, allowing for simultaneous assessments of therapeutic potential and off-target effects. Committed to reducing animal testing, Hesperos is dedicated to supporting the development of treatments for a range of conditions, particularly rare diseases. Through collaborative initiatives with top research institutes and commercial partners, Hesperos aims to accelerate therapeutic development and improve patient outcomes.